Xocova Tablet
Product Images NDC 59630-711

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Xocova (NDC 59630-711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Shionogi Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Xocova 01)

XOCOVA 125 mg oral tablets carton, showing the brand name, generic name Ensitrelvir, dosage strength of 125 mg, and the labeler Shionogi Inc. The packaging appears to be designed for human prescription use.*

FDA Label Image

Chemical Structure (Xocova 02)

Chemical structure diagram of Ensitrelvir, the active ingredient in XOCOVA 125 mg oral tablets by Shionogi Inc.*

FDA Label Image

Figure 1 (Xocova 03)

A line chart showing the proportion of event percentages over days from the start of treatment for two groups: Ensitrelvir (n=1030) with a solid line and Placebo (n=1011) with a dashed line. The x-axis represents the day from treatment start (0 to 10), and the y-axis shows the proportion of events in percentage (0 to 12%). The graph depicts a notably lower event proportion for Ensitrelvir compared to Placebo over time.*

FDA Label Image

Image (Xocova 04)

The image shows a blister pack labeled XOCOVA with a strength of 125 mg. The tablets are arranged in two rows of four, totaling eight tablets. The product is identified as an oral tablet containing the active ingredient Ensitrelvir, manufactured by Shionogi Inc.*

FDA Label Image

Image (Xocova 05)

Packaging label for XOCOVA (ensitrelvir) tablets, 125 mg per tablet, oral dosage form. The label includes dosage instructions mentioning taking 3 tablets as a single dose on Day 1, then 1 tablet once daily on Days 2 through 5. The package contains 7 tablets and is labeled for oral use. Labeler is Shionogi Inc.*

FDA Label Image

Image (Xocova 06)

XOCOVA 125 mg oral tablets blister pack containing 7 round tablets. The blister is labeled with the brand name XOCOVA and generic name ensitrelvir. Dosage instructions indicate use over five days with a specific dosing schedule. Manufactured by Shionogi Inc. and made in the USA. The package includes a barcode and lot/expiration fields.*

FDA Label Image

Image (Xocova 07)

XOCOVA (ensitrelvir) tablets 125 mg per tablet in a blister pack. The label includes oral use instructions specifying taking 3 tablets as a single dose on Day 1, then 1 tablet once daily on Days 2 through 5, at about the same time each day. Manufactured by Shionogi Inc. in Florham Park, NJ, USA. The pack shows dosing days from Day 1 to Day 5 and a barcode.*

FDA Label Image

Principal Display Panel-125 mg Tablet Blister Carton (Xocova 08)

Packaging label for XOCOVA (ensitrelvir) tablets, 125 mg per tablet. The label indicates the product is for oral use and contains 7 tablets. It includes directions for dosing: 3 tablets as a single dose on Day 1, then 1 tablet daily on Days 2 through 5. Labeler is Shionogi Inc., and the NDC number 59630-711-07 is displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.